Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study
Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in...
Gespeichert in:
| Veröffentlicht in: | Critical care (London, England) Jg. 24; H. 1; S. 203 - 14 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
07.05.2020
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection.
Study design
This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection.
Results
The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as
>
14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality).
Conclusion
There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. |
|---|---|
| AbstractList | Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. Study design This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. Results The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). Conclusion There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection.BACKGROUNDThe role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection.This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection.STUDY DESIGNThis is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection.The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality).RESULTSThe 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality).There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection.CONCLUSIONThere are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. Study design This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. Results The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). Conclusion There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. Abstract Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. Study design This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. Results The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). Conclusion There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection. Study design This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection. Results The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality). Conclusion There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection. Keywords: Surgical sepsis, Site of infection, Phenotypes, Chronic critical illness, Heterogeneity, Long-term outcomes, Functional outcomes, Proinflammation, Immunosuppression, Organ dysfunction |
| ArticleNumber | 203 |
| Audience | Academic |
| Author | Moore, Frederick A. Efron, Philip A. Moldawer, Lyle L. Ghita, Gabriela L. Cox, Michael C. Mohr, Alicia M. Stortz, Julie A. Hawkins, Russell B. Brakenridge, Scott C. Brumback, Babette A. |
| Author_xml | – sequence: 1 givenname: Julie A. surname: Stortz fullname: Stortz, Julie A. organization: Department of Surgery, University of Florida College of Medicine – sequence: 2 givenname: Michael C. surname: Cox fullname: Cox, Michael C. organization: Department of Surgery, University of Florida College of Medicine – sequence: 3 givenname: Russell B. surname: Hawkins fullname: Hawkins, Russell B. organization: Department of Surgery, University of Florida College of Medicine – sequence: 4 givenname: Gabriela L. surname: Ghita fullname: Ghita, Gabriela L. organization: Department of Biostatistics, University of Florida – sequence: 5 givenname: Babette A. surname: Brumback fullname: Brumback, Babette A. organization: Department of Biostatistics, University of Florida – sequence: 6 givenname: Alicia M. surname: Mohr fullname: Mohr, Alicia M. organization: Department of Surgery, University of Florida College of Medicine – sequence: 7 givenname: Lyle L. surname: Moldawer fullname: Moldawer, Lyle L. organization: Department of Surgery, University of Florida College of Medicine – sequence: 8 givenname: Philip A. surname: Efron fullname: Efron, Philip A. organization: Department of Surgery, University of Florida College of Medicine – sequence: 9 givenname: Scott C. surname: Brakenridge fullname: Brakenridge, Scott C. organization: Department of Surgery, University of Florida College of Medicine – sequence: 10 givenname: Frederick A. surname: Moore fullname: Moore, Frederick A. email: frederick.moore@surgery.ufl.edu organization: Department of Surgery, University of Florida College of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32381107$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktr3DAUhU1JaR7tH-iiGLrpxqleljVdFELoIxBoF-1aSPK1R8EjuZIdmH_f65k0yYQSjPFF_s7RvdI5LY5CDFAUbyk5p1TJj5lyUouKMILvijYVf1GcUC5FpWpeHz2qj4vTnG8IoY2S_FVxzBlXlJLmpLA_1xDitB29K9cwQYo9BPDTtrTbMvsJytiVPnTgJh8DVmWeU--dGcoMY_b5U2nKMcU8LsQtlEMMvZ_m1ocFwWL7unjZmSHDm7vvWfH765dfl9-r6x_fri4vrisnSTNVynAjLWmIFaylLXe8BiawyVZZEKppV866huDMUnXEEdl2KykVBSO5MwT4WXG1922judFj8huTtjoar3cLMfXapMm7AbS1KOKWMrnioq6F6qzhnEtlpOuMMej1ee81znYDrYMwJTMcmB7-CX6t-3irG0ZkIwgafLgzSPHPDHnSG58dDIMJEOesmSCk5kKsGKLvn6A3cU54fDtKMIEdkgeqNzgA3kjEfd1iqi8ka4QgOAtS5_-h8Glh4x3Gp_O4fiB493jQ-wn_JQQBtgccXnJO0N0jlOglhnofQ40x1LsY6sVVPRE5P5klQdiOH56X8r004z6hh_RwGs-o_gLC_PDH |
| CitedBy_id | crossref_primary_10_1186_s13054_023_04515_5 crossref_primary_10_7759_cureus_54653 crossref_primary_10_3389_fimmu_2022_829210 crossref_primary_10_3390_microorganisms11092165 crossref_primary_10_1186_s13054_024_05215_4 crossref_primary_10_1097_TA_0000000000004087 crossref_primary_10_1186_s40560_021_00576_2 crossref_primary_10_1016_j_surg_2024_01_020 crossref_primary_10_3389_fmed_2022_915224 crossref_primary_10_1097_CCM_0000000000005034 crossref_primary_10_1155_2024_6699274 crossref_primary_10_3389_fimmu_2021_792448 crossref_primary_10_3390_biomedicines11082233 crossref_primary_10_1155_2020_8032806 crossref_primary_10_5114_ait_207612 crossref_primary_10_1002_1873_3468_14999 crossref_primary_10_3389_fimmu_2021_696536 crossref_primary_10_1016_j_ejim_2024_07_019 crossref_primary_10_1096_fj_202002150R crossref_primary_10_1186_s40779_022_00422_y crossref_primary_10_1016_j_jep_2024_119248 crossref_primary_10_2147_JIR_S491137 crossref_primary_10_1016_j_jss_2022_10_096 crossref_primary_10_3390_jcm14155323 crossref_primary_10_3390_jpm14020149 crossref_primary_10_1007_s12519_023_00689_8 crossref_primary_10_1097_SLA_0000000000005067 crossref_primary_10_3390_jcm10153211 crossref_primary_10_1097_CCE_0000000000000554 crossref_primary_10_1007_s00134_021_06574_0 crossref_primary_10_1097_CCE_0000000000000955 crossref_primary_10_3389_fimmu_2025_1627313 crossref_primary_10_3390_microorganisms12081705 crossref_primary_10_1007_s00430_025_00826_2 crossref_primary_10_1186_s13613_025_01513_4 crossref_primary_10_1186_s13054_023_04571_x |
| Cites_doi | 10.1097/TA.0b013e318256e000 10.1097/TA.0b013e31820e7803 10.1016/j.molmed.2014.01.007 10.1177/0885066615627778 10.1097/SHK.0000000000000981 10.1001/archsurg.1990.01410130019002 10.1097/CCM.0b013e31821b827c 10.1097/TA.0000000000001758 10.1001/jama.2016.0287 10.1097/SLA.0000000000003458 10.1001/jamanetworkopen.2018.7571 10.1016/j.jcrc.2009.09.005 10.1001/jama.2019.5791 10.1097/CCM.0000000000001658 10.1378/chest.101.6.1644 10.1097/00000421-198212000-00014 10.1164/rccm.201812-2383CP 10.1164/rccm.201310-1875OC 10.1097/TA.0b013e31821598e9 10.3389/fimmu.2018.01511 10.1007/s00134-003-1662-x 10.1001/jamanetworkopen.2019.8686 10.1097/TA.0000000000000121 10.1001/jama.2018.9071 10.1136/bmj.i2375 10.1186/s40560-019-0383-3 10.1097/CCM.0000000000002011 10.1001/jama.2017.13836 10.1097/00005373-199604000-00001 10.4161/viru.26908 10.1016/j.jcrc.2017.05.019 10.1097/CCM.0000000000000297 10.1136/bmjopen-2016-015136 10.1001/jama.2014.5804 10.1097/CCM.0000000000003655 10.1186/cc8909 10.1111/njs.16435 10.1097/MD.0000000000015276 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s13054-020-02917-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1364-8535 1466-609X 1366-609X |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_bba633b1269345548fba33368a6cfaaa PMC7206740 A627440693 32381107 10_1186_s13054_020_02917_3 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: National Institute of General Medical Sciences grantid: P50 GM-111152; T32 GM-008721 funderid: http://dx.doi.org/10.13039/100000057 – fundername: NIA NIH HHS grantid: P30 AG028740 – fundername: NIGMS NIH HHS grantid: T32 GM-008721 – fundername: NIGMS NIH HHS grantid: P50 GM111152 – fundername: NIGMS NIH HHS grantid: P50 GM-111152 – fundername: NIGMS NIH HHS grantid: T32 GM008721 – fundername: NIGMS NIH HHS grantid: R01 GM105893 – fundername: ; grantid: P50 GM-111152; T32 GM-008721 |
| GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A UKHRP WOQ YOC .6V AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-8a3a6b070b42d1d3c35e24107d8be487d9cbc7013068f0c06df96681ea63ca0e3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 40 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000534031200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1364-8535 1466-609X |
| IngestDate | Fri Oct 03 12:53:13 EDT 2025 Tue Nov 04 02:04:34 EST 2025 Sun Aug 24 03:37:59 EDT 2025 Tue Oct 14 14:12:04 EDT 2025 Sat Nov 29 13:19:34 EST 2025 Sat Nov 29 10:24:39 EST 2025 Mon Jul 21 05:40:29 EDT 2025 Sat Nov 29 06:02:03 EST 2025 Tue Nov 18 21:59:43 EST 2025 Sat Sep 06 07:25:16 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Heterogeneity Phenotypes Immunosuppression Chronic critical illness Proinflammation Functional outcomes Long-term outcomes Site of infection Organ dysfunction Surgical sepsis |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-8a3a6b070b42d1d3c35e24107d8be487d9cbc7013068f0c06df96681ea63ca0e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/bba633b1269345548fba33368a6cfaaa |
| PMID | 32381107 |
| PQID | 2404244550 |
| PQPubID | 44362 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_bba633b1269345548fba33368a6cfaaa pubmedcentral_primary_oai_pubmedcentral_nih_gov_7206740 proquest_miscellaneous_2400534492 proquest_journals_2404244550 gale_infotracmisc_A627440693 gale_infotracacademiconefile_A627440693 pubmed_primary_32381107 crossref_primary_10_1186_s13054_020_02917_3 crossref_citationtrail_10_1186_s13054_020_02917_3 springer_journals_10_1186_s13054_020_02917_3 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-05-07 |
| PublicationDateYYYYMMDD | 2020-05-07 |
| PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Critical care (London, England) |
| PublicationTitleAbbrev | Crit Care |
| PublicationTitleAlternate | Crit Care |
| PublicationYear | 2020 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | JC Marshall (2917_CR7) 2014; 20 N Jeganathan (2917_CR14) 2017; 41 LJ Moore (2917_CR29) 2011; 70 J Marshall (2917_CR4) 1990; 125 IVR Evans (2917_CR17) 2018; 320 JA Stortz (2917_CR27) 2018; 49 CW Seymour (2917_CR10) 2019; 321 JC Marshall (2917_CR31) 2014; 5 HC Prescott (2917_CR36) 2019; 200 MM Levy (2917_CR37) 2003; 29 SC Brakenridge (2917_CR39) 2018; 49 A Leligdowicz (2917_CR12) 2014; 189 C Rhee (2917_CR2) 2017; 318 2917_CR8 T Abe (2917_CR15) 2019; 7 MCV Guilamet (2917_CR9) 2019; 98 E Volakli (2917_CR33) 2010; 14 V Liu (2917_CR1) 2014; 312 MM Oken (2917_CR30) 1982; 5 RB Hawkins (2917_CR25) 2018; 9 2917_CR34 S Lobo (2917_CR11) 2010; 25 CA Croft (2917_CR16) 2014; 76 HC Prescott (2917_CR20) 2016; 353 SC Brakenridge (2917_CR22) 2019; 270 AK Gardner (2917_CR21) 2019; 47 M Singer (2917_CR38) 2016; 315 BA McKinley (2917_CR23) 2011; 70 S Yende (2917_CR40) 2019; 2 C Rhee (2917_CR3) 2019; 2 S Yende (2917_CR19) 2016; 44 JA Stortz (2917_CR26) 2018; 84 RC Bone (2917_CR5) 1992; 101 TJ Loftus (2917_CR28) 2017; 7 FA Moore (2917_CR32) 1996; 40 AR van Zanten (2917_CR18) 2014; 42 ML Martinez (2917_CR35) 2017; 45 CA Motzkus (2917_CR13) 2017; 32 JR Zahar (2917_CR6) 2011; 39 LF Gentile (2917_CR24) 2012; 72 |
| References_xml | – volume: 72 start-page: 1491 year: 2012 ident: 2917_CR24 publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0b013e318256e000 – volume: 70 start-page: 672 issue: 3 year: 2011 ident: 2917_CR29 publication-title: J Trauma doi: 10.1097/TA.0b013e31820e7803 – volume: 20 start-page: 195 year: 2014 ident: 2917_CR7 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2014.01.007 – volume: 32 start-page: 473 year: 2017 ident: 2917_CR13 publication-title: J Intensive Care Med doi: 10.1177/0885066615627778 – volume: 49 start-page: 249 issue: 3 year: 2018 ident: 2917_CR27 publication-title: Shock. doi: 10.1097/SHK.0000000000000981 – volume: 125 start-page: 17 year: 1990 ident: 2917_CR4 publication-title: Arch Surg doi: 10.1001/archsurg.1990.01410130019002 – volume: 39 start-page: 1886 year: 2011 ident: 2917_CR6 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31821b827c – volume: 84 start-page: 342 issue: 2 year: 2018 ident: 2917_CR26 publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001758 – volume: 315 start-page: 801 year: 2016 ident: 2917_CR38 publication-title: JAMA doi: 10.1001/jama.2016.0287 – volume: 270 start-page: 502 year: 2019 ident: 2917_CR22 publication-title: Ann Surg doi: 10.1097/SLA.0000000000003458 – volume: 2 start-page: e187571 issue: 2 year: 2019 ident: 2917_CR3 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2018.7571 – volume: 25 start-page: 391 year: 2010 ident: 2917_CR11 publication-title: J Crit Care doi: 10.1016/j.jcrc.2009.09.005 – ident: 2917_CR8 – volume: 321 start-page: 2003 year: 2019 ident: 2917_CR10 publication-title: JAMA. doi: 10.1001/jama.2019.5791 – volume: 44 start-page: 1461 year: 2016 ident: 2917_CR19 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000001658 – volume: 101 start-page: 1644 year: 1992 ident: 2917_CR5 publication-title: Chest. doi: 10.1378/chest.101.6.1644 – volume: 5 start-page: 649 year: 1982 ident: 2917_CR30 publication-title: Am J Clin Oncol doi: 10.1097/00000421-198212000-00014 – volume: 200 start-page: 972 year: 2019 ident: 2917_CR36 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201812-2383CP – volume: 189 start-page: 1204 year: 2014 ident: 2917_CR12 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201310-1875OC – volume: 70 start-page: 1153 year: 2011 ident: 2917_CR23 publication-title: J Trauma doi: 10.1097/TA.0b013e31821598e9 – volume: 9 start-page: 1511 year: 2018 ident: 2917_CR25 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01511 – volume: 29 start-page: 530 year: 2003 ident: 2917_CR37 publication-title: Intensive Care Med doi: 10.1007/s00134-003-1662-x – volume: 2 start-page: e198686 issue: 8 year: 2019 ident: 2917_CR40 publication-title: JAMA New Open doi: 10.1001/jamanetworkopen.2019.8686 – volume: 76 start-page: 311 year: 2014 ident: 2917_CR16 publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000000121 – volume: 320 start-page: 358 year: 2018 ident: 2917_CR17 publication-title: JAMA. doi: 10.1001/jama.2018.9071 – volume: 353 start-page: i2375 year: 2016 ident: 2917_CR20 publication-title: BMJ. doi: 10.1136/bmj.i2375 – volume: 7 start-page: 28 year: 2019 ident: 2917_CR15 publication-title: J Intensive Care doi: 10.1186/s40560-019-0383-3 – volume: 45 start-page: 11 year: 2017 ident: 2917_CR35 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000002011 – volume: 318 start-page: 1241 year: 2017 ident: 2917_CR2 publication-title: JAMA. doi: 10.1001/jama.2017.13836 – volume: 40 start-page: 501 year: 1996 ident: 2917_CR32 publication-title: J Trauma doi: 10.1097/00005373-199604000-00001 – volume: 5 start-page: 27 year: 2014 ident: 2917_CR31 publication-title: Virulence doi: 10.4161/viru.26908 – volume: 41 start-page: 170 year: 2017 ident: 2917_CR14 publication-title: J Crit Care doi: 10.1016/j.jcrc.2017.05.019 – volume: 42 start-page: 1890 year: 2014 ident: 2917_CR18 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000000297 – volume: 7 start-page: e015136 issue: 7 year: 2017 ident: 2917_CR28 publication-title: BMJ Open doi: 10.1136/bmjopen-2016-015136 – volume: 49 start-page: 138 issue: Suppl 6 year: 2018 ident: 2917_CR39 publication-title: Shock – volume: 312 start-page: 90 year: 2014 ident: 2917_CR1 publication-title: JAMA. doi: 10.1001/jama.2014.5804 – volume: 47 start-page: 566 year: 2019 ident: 2917_CR21 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000003655 – volume: 14 start-page: R32 issue: 2 year: 2010 ident: 2917_CR33 publication-title: Crit Care doi: 10.1186/cc8909 – ident: 2917_CR34 doi: 10.1111/njs.16435 – volume: 98 issue: 16 year: 2019 ident: 2917_CR9 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000015276 |
| SSID | ssj0017863 |
| Score | 2.4943433 |
| Snippet | Background
The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased,... The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many... Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased,... Abstract Background The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 203 |
| SubjectTerms | Abdomen Activities of daily living Aged Chronic critical illness Clinical trials Cohort Studies Comorbidity Critical care Critical Care Medicine Critical Illness - epidemiology Cross infection Disability Emergency Medicine Epidemiology Female Health aspects Heterogeneity Hospital Mortality - trends Hospital patients Hospitals Humans Hypotheses Illnesses Immunotherapy Infections Intensive Intensive care Long-term outcomes Longitudinal Studies Male Medical records Medical research Medicine Medicine & Public Health Middle Aged Mortality Patients Phenotype Phenotypes Pneumonia Postoperative Complications - etiology Prospective Studies Risk Factors Sepsis Sepsis - classification Sepsis - etiology Site of infection Surgery Surgical sepsis Surgical Wound Infection - classification Surgical Wound Infection - complications Trauma Ventilators Viral infections |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSF9yNQkJGQOIBVJ05shwsqiIoDVD0A2ptlOw67UpUsm12k_ntmvM6WFNELt83aTuzMeB7xzDeEvAQNqXxRBya0BwcFTHZmFfcslwUmfWntYjTh98_q-FjPZvVJ-uA2pLDKUSZGQd30Hr-RH4DmwZwsMKjfLX8yrBqFp6uphMZVcg3LZiOfq9nO4cqVjpXUciFLBmqpGpNmtDwYQHZXJUPniRfgsjAxUUwRv_9vKf2HmroYQnnhHDWqp6Pb_7uwO-RWMkzp4ZaT7pIrobtHbnxJR-_3iTuZh65fny0Xns4xhqYH1gtgw1N3RvFetG_pGNrVwS86bFZRrNIhLIfF8JZaClMbUzvpaY-lkjYNluWiEeX2Afl29PHrh08sFWhgXnK1ZtoKKx0IDVcWTd4IL6oAFgFXjXYBPKGm9s4rPBuVuuWey6YF70rnwUrhLQ_iIdnr-i48JjRUtm2AM-oK3GRettrXvILLsrAl4idmJB-pY3xCL8ciGqcmejFami1FDVDURIoakZHXuzHLLXbHpb3fI9F3PRF3O_7Rr36YtI2NczB14fJC1gJIVurWWSGE1Fb61lqbkVfIMgalA0zP25TkAItEnC1zKCMiI4zOyP6kJ-xqP20eucUkqTKYc1bJyItdM47ESLku9JvYB-QqvrOMPNry6G5JAu0zIE9G1IR7J2uetnSLecQcVwjzX8Jz34x8fj6tf7_TJ5ev4im5WcQdWDGu9sneerUJz8h1_2u9GFbP417-Dd9_TRE priority: 102 providerName: ProQuest – databaseName: Springer Nature - Connect here FIRST to enable access dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQwcAQFIS7lDYGCjITEASKcOLEdbgVRcYCq4lH1ZtmOw65UJavNbqX-PTPeZCHlIcFtdz3Wesbz1DwM8AwtpPJ5FVKhPQYo6LKnVnGfZjKnpi-tXawmPP6gDg_1yUl1NDSF9WO1-5iSjJo6irWWr3rUtmWRUrjDcwwyUnEZrqC50_Rgw6fPx9vcgdJSjO0xv903MUFxUv-v-vgng3SxWPJCxjQaooMb_4fCTdgdHE-2v-GUW3AptLfh2schtX4H3NEstN3qfDH3bEY1Mh2yVkAfnblzRilm1jVsLN1q8RPr18uoNlkfFv28f80sQ7zG1k122tFTSOuant1icYrtXfh68O7L2_fp8ABD6iVXq1RbYaVDpeCKvM5q4UUZ0OJzVWsXMNKpK--8otyn1A33XNYNRk86C1YKb3kQ92Cn7drwAFgobVPjzVclhsG8aLSveIlfi9wWNB8xgWy8E-OH6eT0SMapiVGKlmZDPIPEM5F4RiTwYrtnsZnN8VfoN3TVW0iaqx1_6JbfzCCmxjk8unBZLitRoKelG2eFEFJb6RtrbQLPiVEMST8ez9uhiQGRpDlaZl_GiYu4O4G9CSRKrZ8uj6xmBq3RG_SuqO8Qg8YEnm6XaSdVwrWhW0cY1JtEswTubzhzi5Ig_wuvJwE14dkJztOVdj6LM8UVjfEv8H9fjpz741h_punDfwN_BNfzyPxlytUe7KyW6_AYrvqz1bxfPolS_B34REFn priority: 102 providerName: Springer Nature |
| Title | Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study |
| URI | https://link.springer.com/article/10.1186/s13054-020-02917-3 https://www.ncbi.nlm.nih.gov/pubmed/32381107 https://www.proquest.com/docview/2404244550 https://www.proquest.com/docview/2400534492 https://pubmed.ncbi.nlm.nih.gov/PMC7206740 https://doaj.org/article/bba633b1269345548fba33368a6cfaaa |
| Volume | 24 |
| WOSCitedRecordID | wos000534031200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RBZ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1364-8535 dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RSV dateStart: 19970401 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgIMQL4pvAqIyExANEc-LEdnjb0CaQWFUNmMqTZTuOWmlKqqZF2n_PnZOUZQh44aWqa1u178N3J59_R8hrsJDSpYWPuXIQoIDLHhvJXJyIFB99KWVDNuH5Zzmdqvm8mF0p9YU5YR08cEe4A2uN4NwmqSh4BrZPVdZwzoUywlXGBNeIyWIIpvr7A6kEH57IKHHQwkmdZzGGSiyFACXmIzMU0Pp_P5OvGKXrCZPXbk2DMTq5T-71XiQ97Fb_gNzw9UNy57S_J39E7Gzh62ZzuVo6usCElwbkxIPDTe0lxfti2lR0yMOq4Rttt-twBtLWr9pl-54aCgsc3mHSiwbrGm1LrKFFAyTtY_Lt5Pjrh49xX00hdoLJTawMN8KChtssLZOSO557MN9Mlsp6CFvKwlkn8SJTqIo5JsoKQiGVeKC_M8zzJ2Svbmr_jFCfm6oENhY5xLQsq5QrWA7NLDUZgh1GJBmIq10PNY4VLy50CDmU0B1DNDBEB4ZoHpG3uzmrDmjjr6OPkGe7kQiSHX4A0dG96Oh_iU5E3iDHNaoyLM-Z_kUCbBJBsfShCPCJMDsi-6ORoIJu3D3IjO6PgFaDq4SPCCECjMirXTfOxLS22jfbMAYOQaRZRJ52IrbbEkdnCtgTETkSvtGexz31chEAwiVi8mfwv-8GMf21rD_T9Pn_oOkLcjcNapbHTO6Tvc1661-S2-7HZtmuJ-SmnMvwqSbk1tHxdHY2CYoLrdmn09l3aJ19Of8JGilD7g |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQMAL90tggJFAPIC1JE5sBwmhcZk2rZv2MKa-GcdxaKUpKU0L6p_iN3KOm3RkiL3tgbe2thNfvnOrz4WQFyAhpY0zx7iyYKCAys6MDC2LRIxBX0rl3pvweCAPDtRwmB2ukV9dLAy6VXY80TPqorb4H_kmSB6MyQKF-v3kO8OqUXi72pXQWMJizy1-gsnWvNv9BOf7Mo63Px993GFtVQFmRShnTBluRA5Iz5O4iApueepAjIWyULkD9b3IbG4lXugJVYY2FEUJJoGKnBHcmtBxeO4lchn4uERjTw5XBl4kla_cFnGRMBCDaReko8RmA89LE4bGWhiDicR4TxD6egF_S4U_xOJZl80z97ZeHG7f_N828ha50SredGtJKbfJmqvukKv7rWvBXZIfjlxVzxaTsaUj9BGqgbQc2Cg0X1CcO61L2rmuVfCJNvOpFxu0cZNm3LylhsJWdKGr9KTGUlDzAsuOUZ_F9x75ciErvE_Wq7pyDwl1qSkLQH6WxhIOoFQ2C1P4msQmwfyQAYk6NGjbZmfHIiEn2ltpSuglgjQgSHsEaR6Q16sxk2VuknN7f0CQrXpiXnH_Qz39pls2pfMcps7zKBYZB4gkqswN51woI2xpjAnIK4SoRu4H07OmDeKARWIeMb0lfMZJGB2QjV5P4Fq239yhU7dcs9Gn0AzI81UzjkRPwMrVc98H5AbuWUAeLGlitSSO-iccT0Bkj1p6a-63VOORz6kusYxBAu9909HV6bT-vaePzl_FM3Jt52h_oAe7B3uPyfXYU3_KQrlB1mfTuXtCrtgfs3Ezfer5CCVfL5refgPpual6 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BQBMvfA8CA4yExANES-PEcXgbHxWIUVUCpr1ZtuPQSlNSNSnS_nvunKQs40NCvLW1rfrOd-c73d3PAM_whsxsnLuQS4sBCrrsoc4iG05ETE1fUhpfTXh8lM1m8uQkn5_r4vfV7kNKsutpIJSmqj1YFWWn4lIcNGh50ySk0CeKMeAI-WW4klAhPcXrn4-3eYRMCj60yvx23eg68qj9v9rmc5fTxcLJC9lTfylNb_w_OTfheu-QssNOgm7BJVfdht1Pfcr9Dpj5wlV1e7ZaWrag2pkaRc6h787MGaPUM6tLNpR0VfiJNZu1N6escatm2bximiGNQ0snO63piaRNQc9xMY9uexe-Tt99efM-7B9mCK2IsjaUmmth0FiYJC4mBbc8degJRFkhjcMIqMitsRnlRIUsIxuJosSoSk6cFtzqyPE92Knqyt0H5lJdFigReYrhcZSU0uZRil-TWCeEmxjAZDgfZXvUcno841T56EUK1TFPIfOUZ57iAbzYrll1mB1_nf2ajn07k_C2_Q_1-pvq1VcZg1vnZhKLnCfogcnSaM65kFrYUmsdwHMSGkVWAbdndd_cgEQSvpY6FB6JEVcHsD-aidpsx8OD2KnemjQKvS7qR8RgMoCn22FaSRVylas3fg7aU-JZAPc6Kd2SxMkvw-MJIBvJ74jm8Ui1XHis8Yzg_RP835eDFP_c1p95-uDfpj-B3fnbqTr6MPv4EK7FXg_SMMr2Yaddb9wjuGq_t8tm_dgr9w_HNU0v |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phenotypic+heterogeneity+by+site+of+infection+in+surgical+sepsis%3A+a+prospective+longitudinal+study&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Julie+A.+Stortz&rft.au=Michael+C.+Cox&rft.au=Russell+B.+Hawkins&rft.au=Gabriela+L.+Ghita&rft.date=2020-05-07&rft.pub=BMC&rft.eissn=1364-8535&rft.volume=24&rft.issue=1&rft.spage=1&rft.epage=14&rft_id=info:doi/10.1186%2Fs13054-020-02917-3&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bba633b1269345548fba33368a6cfaaa |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |